This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Impetis Biosciences Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Journey of Manoj Joshi
Introduction
Manoj Joshi is a notable inventor based in Mumbai, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on fused bicyclic compounds. His research focuses on developing compounds that serve as inhibitors of GPR91, which have potential applications in various medical conditions.
Latest Patents
Manoj Joshi holds a patent for "Fused bicyclic compounds, compositions and applications thereof." This patent describes fused bicyclic compounds that are effective inhibitors of GPR91. The compounds, along with their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions, are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to the inhibition of GPR91. He has 1 patent to his name.
Career Highlights
Manoj Joshi is currently associated with Impetis Biosciences Limited, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community for its potential impact on therapeutic strategies.
Collaborations
Some of his notable coworkers include Nadim Shaikh and Mahesh Thakkar, who contribute to the collaborative environment at Impetis Biosciences Limited.
Conclusion
Manoj Joshi's innovative work in the field of medicinal chemistry exemplifies the importance of research in developing new therapeutic options. His contributions, particularly in the area of GPR91 inhibition, highlight the potential for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile